These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20955770)

  • 41. Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice.
    Meijboom KE; Sutton ER; McCallion E; McFall E; Anthony D; Edwards B; Kubinski S; Tapken I; Bünermann I; Hazell G; Ahlskog N; Claus P; Davies KE; Kothary R; Wood MJA; Bowerman M
    Skelet Muscle; 2022 Jul; 12(1):18. PubMed ID: 35902978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.
    Mittal A; Bhatnagar S; Kumar A; Lach-Trifilieff E; Wauters S; Li H; Makonchuk DY; Glass DJ; Kumar A
    J Cell Biol; 2010 Mar; 188(6):833-49. PubMed ID: 20308426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytokine cooperation in renal tubular cell injury: the role of TWEAK.
    Justo P; Sanz AB; Sanchez-Niño MD; Winkles JA; Lorz C; Egido J; Ortiz A
    Kidney Int; 2006 Nov; 70(10):1750-8. PubMed ID: 17003819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus.
    Doerner JL; Wen J; Xia Y; Paz KB; Schairer D; Wu L; Chalmers SA; Izmirly P; Michaelson JS; Burkly LC; Friedman AJ; Putterman C
    J Invest Dermatol; 2015 Aug; 135(8):1986-1995. PubMed ID: 25826425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
    Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
    Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation.
    Cheng H; Xu M; Liu X; Zou X; Zhan N; Xia Y
    Exp Dermatol; 2016 Jan; 25(1):32-7. PubMed ID: 26264384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury.
    Serafini B; Magliozzi R; Rosicarelli B; Reynolds R; Zheng TS; Aloisi F
    J Neuropathol Exp Neurol; 2008 Dec; 67(12):1137-48. PubMed ID: 19018248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.
    Kawashima R; Kawamura YI; Oshio T; Son A; Yamazaki M; Hagiwara T; Okada T; Inagaki-Ohara K; Wu P; Szak S; Kawamura YJ; Konishi F; Miyake O; Yano H; Saito Y; Burkly LC; Dohi T
    Gastroenterology; 2011 Dec; 141(6):2119-2129.e8. PubMed ID: 21893119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
    Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
    Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade.
    van Kuijk AW; Wijbrandts CA; Vinkenoog M; Zheng TS; Reedquist KA; Tak PP
    Ann Rheum Dis; 2010 Jan; 69(1):301-4. PubMed ID: 19147618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.
    Peng QL; Shu XM; Tian XL; Lu X; Wang GC
    Arthritis Res Ther; 2014 Jan; 16(1):R26. PubMed ID: 24467773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
    Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
    Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis.
    Méndez-Barbero N; Gutierrez-Muñoz C; Madrigal-Matute J; Mínguez P; Egido J; Michel JB; Martín-Ventura JL; Esteban V; Blanco-Colio LM
    EBioMedicine; 2019 Aug; 46():274-289. PubMed ID: 31395500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor Necrosis Factor (TNF) Receptor Expression Determines Keratinocyte Fate upon Stimulation with TNF-Like Weak Inducer of Apoptosis.
    Wang X; Cheng D; Hu G; Liang L; Tan F; Xiao T; Xiao S; Xia Y
    Mediators Inflamm; 2019; 2019():2945083. PubMed ID: 31885495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.
    Xia Y; Campbell SR; Broder A; Herlitz L; Abadi M; Wu P; Michaelson JS; Burkly LC; Putterman C
    Clin Immunol; 2012 Nov; 145(2):108-21. PubMed ID: 22982296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.
    Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH
    J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TWEAK-Fn14 Axis Induces Calcium-Associated Autophagy and Cell Death To Control Mycobacterial Survival in Macrophages.
    Chen YM; Liu PY; Tang KT; Liu HJ; Liao TL
    Microbiol Spectr; 2022 Dec; 10(6):e0317222. PubMed ID: 36321903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-кB pathway.
    Chen HN; Wang DJ; Ren MY; Wang QL; Sui SJ
    Mol Biol Rep; 2012 Aug; 39(8):8231-41. PubMed ID: 22555979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity.
    Zaitseva O; Hoffmann A; Löst M; Anany MA; Zhang T; Kucka K; Wiegering A; Otto C; Wajant H
    Front Immunol; 2023; 14():1194610. PubMed ID: 37545514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TWEAK and the central nervous system.
    Yepes M
    Mol Neurobiol; 2007 Jun; 35(3):255-65. PubMed ID: 17917114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.